Form 4: Vicor Director Exercises Options, Sells Stock

Vicor Corp. Director Andrew D'Amico reported exercising stock options and selling common stock on November 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Vicor Corp. Director Andrew D'Amico reported transactions on November 12, 2025, involving the exercise of non-qualified stock options and the subsequent sale of common stock.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2024.
• D'Amico acquired 577 shares of common stock at an exercise price of $69.04 and immediately sold them at $98.44 per share.
• Another block of 577 shares was acquired at $69.04 and sold at $100 per share.
• A third block of 754 shares was acquired at $53.07 and sold at $99 per share.
• Following these transactions, D'Amico's direct beneficial ownership of these specific common stock blocks is zero, as the acquired shares were immediately disposed of.
• D'Amico continues to beneficially own 3,015 non-qualified stock options.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While it's insider selling, it's pre-planned and involves option exercises, which is a common and expected part of executive compensation. The sales are at a profit relative to exercise prices.

Positives

• The insider sales were executed at prices significantly higher than the option exercise prices, indicating a profitable transaction for the director.
• The transactions were conducted under a Rule 10b5-1 trading plan, which suggests a pre-planned, systematic approach to managing equity holdings rather than reactive selling based on new information.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived negatively by the market, potentially leading to minor downward pressure or investor caution.

Future Outlook

The filing details completed insider transactions for November 2025, reflecting a pre-determined strategy for managing equity holdings rather than a reaction to immediate market conditions. The remaining options provide future equity upside potential for the director.

Management Comments

• The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are a routine aspect of executive compensation and personal financial planning across all industries. They allow insiders to sell shares without being accused of trading on material non-public information, as the plan is established when no such information is held. For technology companies like Vicor, which often grant stock options as a significant part of compensation, such filings are common.

Comparison to Industry Standards

• The transactions are standard for an insider exercising options and selling shares under a pre-arranged 10b5-1 plan. This practice is widely adopted by executives in publicly traded companies to manage their equity compensation and diversify personal portfolios while adhering to SEC regulations. No specific comparable companies or projects are mentioned in the filing to allow for a direct comparison of results.

Stakeholder Impact

• Shareholders: May view insider selling, even if planned, with slight caution, but the context of option exercise and 10b5-1 plan mitigates negative perception.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

The filing details routine insider transactions (option exercises and sales) executed under a pre-established 10b5-1 plan. This type of activity is common for executives managing their equity compensation and does not typically signal a change in the company's fundamental outlook or performance. The sales are at a profit relative to the exercise prices, which is a positive for the insider but neutral for the stock's valuation. Without additional information on company performance or market conditions, these transactions alone do not warrant a change from a 'hold' recommendation.

Keywords

Vicor Corp, VICR, Form 4, Insider Trading, Stock Options, 10b5-1 Plan, Andrew D'Amico, Director, Equity Sales